Global Monoclonal Antibody Biologics and Biosimilars Supply, Demand and Key Producers, 2023-2029
The global Monoclonal Antibody Biologics and Biosimilars market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies the global Monoclonal Antibody Biologics and Biosimilars demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Monoclonal Antibody Biologics and Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Monoclonal Antibody Biologics and Biosimilars total market, 2018-2029, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Monoclonal Antibody Biologics and Biosimilars total market, key domestic companies and share, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars revenue by player and market share 2018-2023, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by Type, CAGR, 2018-2029, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Monoclonal Antibody Biologics and Biosimilars market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Monoclonal Antibody Biologics and Biosimilars market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Monoclonal Antibody Biologics and Biosimilars Market, By Region:
1. How big is the global Monoclonal Antibody Biologics and Biosimilars market?
2. What is the demand of the global Monoclonal Antibody Biologics and Biosimilars market?
3. What is the year over year growth of the global Monoclonal Antibody Biologics and Biosimilars market?
4. What is the total value of the global Monoclonal Antibody Biologics and Biosimilars market?
5. Who are the major players in the global Monoclonal Antibody Biologics and Biosimilars market?
6. What are the growth factors driving the market demand?
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies the global Monoclonal Antibody Biologics and Biosimilars demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Monoclonal Antibody Biologics and Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Monoclonal Antibody Biologics and Biosimilars total market, 2018-2029, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Monoclonal Antibody Biologics and Biosimilars total market, key domestic companies and share, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars revenue by player and market share 2018-2023, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by Type, CAGR, 2018-2029, (USD Million)
Global Monoclonal Antibody Biologics and Biosimilars total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Monoclonal Antibody Biologics and Biosimilars market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Monoclonal Antibody Biologics and Biosimilars market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Monoclonal Antibody Biologics and Biosimilars Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Biologics
- Biosimilars
- Cancer
- Autoimmune Disease
- Other
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Eli Lilly
- Novartis
- Merck
- Biogen
- Celltrion
- Sobi
- 3SBIO
- Innovent Biologics
1. How big is the global Monoclonal Antibody Biologics and Biosimilars market?
2. What is the demand of the global Monoclonal Antibody Biologics and Biosimilars market?
3. What is the year over year growth of the global Monoclonal Antibody Biologics and Biosimilars market?
4. What is the total value of the global Monoclonal Antibody Biologics and Biosimilars market?
5. Who are the major players in the global Monoclonal Antibody Biologics and Biosimilars market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Monoclonal Antibody Biologics and Biosimilars Introduction
1.2 World Monoclonal Antibody Biologics and Biosimilars Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Monoclonal Antibody Biologics and Biosimilars Total Market by Region (by Headquarter Location)
1.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.3 China Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.4 Europe Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.5 Japan Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.6 South Korea Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.7 ASEAN Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.8 India Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Monoclonal Antibody Biologics and Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Monoclonal Antibody Biologics and Biosimilars Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.2 World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region
2.2.1 World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region (2018-2023)
2.2.2 World Monoclonal Antibody Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029)
2.3 United States Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.4 China Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.5 Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.6 Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.7 South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.8 ASEAN Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.9 India Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
3 WORLD MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS COMPANIES COMPETITIVE ANALYSIS
3.1 World Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Monoclonal Antibody Biologics and Biosimilars Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Monoclonal Antibody Biologics and Biosimilars in 2022
3.2.3 Global Concentration Ratios (CR8) for Monoclonal Antibody Biologics and Biosimilars in 2022
3.3 Monoclonal Antibody Biologics and Biosimilars Company Evaluation Quadrant
3.4 Monoclonal Antibody Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.4.1 Monoclonal Antibody Biologics and Biosimilars Market: Region Footprint
3.4.2 Monoclonal Antibody Biologics and Biosimilars Market: Company Product Type Footprint
3.4.3 Monoclonal Antibody Biologics and Biosimilars Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison
4.2.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Monoclonal Antibody Biologics and Biosimilars Companies and Market Share, 2018-2023
4.3.1 United States Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
4.4 China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue and Market Share, 2018-2023
4.4.1 China Based Monoclonal Antibody Biologics and Biosimilars Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
4.5 Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Monoclonal Antibody Biologics and Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biologics
5.2.2 Biosimilars
5.3 Market Segment by Type
5.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2018-2023)
5.3.2 World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2024-2029)
5.3.3 World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Monoclonal Antibody Biologics and Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Disease
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2023)
6.3.2 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2024-2029)
6.3.3 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Product and Services
7.1.4 Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Product and Services
7.2.4 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Product and Services
7.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Product and Services
7.4.4 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product and Services
7.5.4 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Product and Services
7.6.4 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product and Services
7.7.4 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Novartis
7.8.1 Novartis Details
7.8.2 Novartis Major Business
7.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Product and Services
7.8.4 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis Recent Developments/Updates
7.8.6 Novartis Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Product and Services
7.9.4 Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Biogen
7.10.1 Biogen Details
7.10.2 Biogen Major Business
7.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Product and Services
7.10.4 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Biogen Recent Developments/Updates
7.10.6 Biogen Competitive Strengths & Weaknesses
7.11 Celltrion
7.11.1 Celltrion Details
7.11.2 Celltrion Major Business
7.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Product and Services
7.11.4 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Celltrion Recent Developments/Updates
7.11.6 Celltrion Competitive Strengths & Weaknesses
7.12 Sobi
7.12.1 Sobi Details
7.12.2 Sobi Major Business
7.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Product and Services
7.12.4 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sobi Recent Developments/Updates
7.12.6 Sobi Competitive Strengths & Weaknesses
7.13 3SBIO
7.13.1 3SBIO Details
7.13.2 3SBIO Major Business
7.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Product and Services
7.13.4 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 3SBIO Recent Developments/Updates
7.13.6 3SBIO Competitive Strengths & Weaknesses
7.14 Innovent Biologics
7.14.1 Innovent Biologics Details
7.14.2 Innovent Biologics Major Business
7.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product and Services
7.14.4 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Innovent Biologics Recent Developments/Updates
7.14.6 Innovent Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Monoclonal Antibody Biologics and Biosimilars Industry Chain
8.2 Monoclonal Antibody Biologics and Biosimilars Upstream Analysis
8.3 Monoclonal Antibody Biologics and Biosimilars Midstream Analysis
8.4 Monoclonal Antibody Biologics and Biosimilars Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Monoclonal Antibody Biologics and Biosimilars Introduction
1.2 World Monoclonal Antibody Biologics and Biosimilars Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Monoclonal Antibody Biologics and Biosimilars Total Market by Region (by Headquarter Location)
1.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.3 China Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.4 Europe Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.5 Japan Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.6 South Korea Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.7 ASEAN Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.3.8 India Monoclonal Antibody Biologics and Biosimilars Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Monoclonal Antibody Biologics and Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Monoclonal Antibody Biologics and Biosimilars Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.2 World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region
2.2.1 World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region (2018-2023)
2.2.2 World Monoclonal Antibody Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029)
2.3 United States Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.4 China Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.5 Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.6 Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.7 South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.8 ASEAN Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
2.9 India Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029)
3 WORLD MONOCLONAL ANTIBODY BIOLOGICS AND BIOSIMILARS COMPANIES COMPETITIVE ANALYSIS
3.1 World Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Monoclonal Antibody Biologics and Biosimilars Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Monoclonal Antibody Biologics and Biosimilars in 2022
3.2.3 Global Concentration Ratios (CR8) for Monoclonal Antibody Biologics and Biosimilars in 2022
3.3 Monoclonal Antibody Biologics and Biosimilars Company Evaluation Quadrant
3.4 Monoclonal Antibody Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.4.1 Monoclonal Antibody Biologics and Biosimilars Market: Region Footprint
3.4.2 Monoclonal Antibody Biologics and Biosimilars Market: Company Product Type Footprint
3.4.3 Monoclonal Antibody Biologics and Biosimilars Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison
4.2.1 United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Monoclonal Antibody Biologics and Biosimilars Companies and Market Share, 2018-2023
4.3.1 United States Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
4.4 China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue and Market Share, 2018-2023
4.4.1 China Based Monoclonal Antibody Biologics and Biosimilars Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
4.5 Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Monoclonal Antibody Biologics and Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biologics
5.2.2 Biosimilars
5.3 Market Segment by Type
5.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2018-2023)
5.3.2 World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2024-2029)
5.3.3 World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Monoclonal Antibody Biologics and Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Disease
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2023)
6.3.2 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2024-2029)
6.3.3 World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Product and Services
7.1.4 Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Product and Services
7.2.4 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Product and Services
7.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Product and Services
7.4.4 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product and Services
7.5.4 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Product and Services
7.6.4 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product and Services
7.7.4 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Novartis
7.8.1 Novartis Details
7.8.2 Novartis Major Business
7.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Product and Services
7.8.4 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis Recent Developments/Updates
7.8.6 Novartis Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Product and Services
7.9.4 Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Biogen
7.10.1 Biogen Details
7.10.2 Biogen Major Business
7.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Product and Services
7.10.4 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Biogen Recent Developments/Updates
7.10.6 Biogen Competitive Strengths & Weaknesses
7.11 Celltrion
7.11.1 Celltrion Details
7.11.2 Celltrion Major Business
7.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Product and Services
7.11.4 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Celltrion Recent Developments/Updates
7.11.6 Celltrion Competitive Strengths & Weaknesses
7.12 Sobi
7.12.1 Sobi Details
7.12.2 Sobi Major Business
7.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Product and Services
7.12.4 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sobi Recent Developments/Updates
7.12.6 Sobi Competitive Strengths & Weaknesses
7.13 3SBIO
7.13.1 3SBIO Details
7.13.2 3SBIO Major Business
7.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Product and Services
7.13.4 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 3SBIO Recent Developments/Updates
7.13.6 3SBIO Competitive Strengths & Weaknesses
7.14 Innovent Biologics
7.14.1 Innovent Biologics Details
7.14.2 Innovent Biologics Major Business
7.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product and Services
7.14.4 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Innovent Biologics Recent Developments/Updates
7.14.6 Innovent Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Monoclonal Antibody Biologics and Biosimilars Industry Chain
8.2 Monoclonal Antibody Biologics and Biosimilars Upstream Analysis
8.3 Monoclonal Antibody Biologics and Biosimilars Midstream Analysis
8.4 Monoclonal Antibody Biologics and Biosimilars Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Monoclonal Antibody Biologics and Biosimilars Players in 2022
Table 12. World Monoclonal Antibody Biologics and Biosimilars Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Monoclonal Antibody Biologics and Biosimilars Company Evaluation Quadrant
Table 14. Head Office of Key Monoclonal Antibody Biologics and Biosimilars Player
Table 15. Monoclonal Antibody Biologics and Biosimilars Market: Company Product Type Footprint
Table 16. Monoclonal Antibody Biologics and Biosimilars Market: Company Product Application Footprint
Table 17. Monoclonal Antibody Biologics and Biosimilars Mergers & Acquisitions Activity
Table 18. United States VS China Monoclonal Antibody Biologics and Biosimilars Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 21. United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 23. China Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (Province, Country)
Table 24. China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 26. Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 29. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2018-2023) & (USD Million)
Table 31. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2024-2029) & (USD Million)
Table 32. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2023) & (USD Million)
Table 34. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 38. Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 44. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 50. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 56. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 62. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 68. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Eli Lilly Basic Information, Area Served and Competitors
Table 72. Eli Lilly Major Business
Table 73. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 74. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly Recent Developments/Updates
Table 76. Eli Lilly Competitive Strengths & Weaknesses
Table 77. Novartis Basic Information, Area Served and Competitors
Table 78. Novartis Major Business
Table 79. Novartis Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 80. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis Recent Developments/Updates
Table 82. Novartis Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Area Served and Competitors
Table 84. Merck Major Business
Table 85. Merck Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 86. Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Biogen Basic Information, Area Served and Competitors
Table 90. Biogen Major Business
Table 91. Biogen Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 92. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Biogen Recent Developments/Updates
Table 94. Biogen Competitive Strengths & Weaknesses
Table 95. Celltrion Basic Information, Area Served and Competitors
Table 96. Celltrion Major Business
Table 97. Celltrion Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 98. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Celltrion Recent Developments/Updates
Table 100. Celltrion Competitive Strengths & Weaknesses
Table 101. Sobi Basic Information, Area Served and Competitors
Table 102. Sobi Major Business
Table 103. Sobi Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 104. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sobi Recent Developments/Updates
Table 106. Sobi Competitive Strengths & Weaknesses
Table 107. 3SBIO Basic Information, Area Served and Competitors
Table 108. 3SBIO Major Business
Table 109. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 110. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. 3SBIO Recent Developments/Updates
Table 112. Innovent Biologics Basic Information, Area Served and Competitors
Table 113. Innovent Biologics Major Business
Table 114. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 115. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Monoclonal Antibody Biologics and Biosimilars Upstream (Raw Materials)
Table 117. Monoclonal Antibody Biologics and Biosimilars Typical Customers
Table 1. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Monoclonal Antibody Biologics and Biosimilars Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Monoclonal Antibody Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Monoclonal Antibody Biologics and Biosimilars Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Monoclonal Antibody Biologics and Biosimilars Players in 2022
Table 12. World Monoclonal Antibody Biologics and Biosimilars Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Monoclonal Antibody Biologics and Biosimilars Company Evaluation Quadrant
Table 14. Head Office of Key Monoclonal Antibody Biologics and Biosimilars Player
Table 15. Monoclonal Antibody Biologics and Biosimilars Market: Company Product Type Footprint
Table 16. Monoclonal Antibody Biologics and Biosimilars Market: Company Product Application Footprint
Table 17. Monoclonal Antibody Biologics and Biosimilars Mergers & Acquisitions Activity
Table 18. United States VS China Monoclonal Antibody Biologics and Biosimilars Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Monoclonal Antibody Biologics and Biosimilars Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 21. United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 23. China Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (Province, Country)
Table 24. China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 26. Rest of World Based Monoclonal Antibody Biologics and Biosimilars Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Monoclonal Antibody Biologics and Biosimilars Revenue Market Share (2018-2023)
Table 29. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2018-2023) & (USD Million)
Table 31. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type (2024-2029) & (USD Million)
Table 32. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2018-2023) & (USD Million)
Table 34. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 38. Roche Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 44. Amgen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 50. AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 56. Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 62. Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 68. Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Eli Lilly Basic Information, Area Served and Competitors
Table 72. Eli Lilly Major Business
Table 73. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 74. Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly Recent Developments/Updates
Table 76. Eli Lilly Competitive Strengths & Weaknesses
Table 77. Novartis Basic Information, Area Served and Competitors
Table 78. Novartis Major Business
Table 79. Novartis Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 80. Novartis Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis Recent Developments/Updates
Table 82. Novartis Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Area Served and Competitors
Table 84. Merck Major Business
Table 85. Merck Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 86. Merck Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Biogen Basic Information, Area Served and Competitors
Table 90. Biogen Major Business
Table 91. Biogen Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 92. Biogen Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Biogen Recent Developments/Updates
Table 94. Biogen Competitive Strengths & Weaknesses
Table 95. Celltrion Basic Information, Area Served and Competitors
Table 96. Celltrion Major Business
Table 97. Celltrion Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 98. Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Celltrion Recent Developments/Updates
Table 100. Celltrion Competitive Strengths & Weaknesses
Table 101. Sobi Basic Information, Area Served and Competitors
Table 102. Sobi Major Business
Table 103. Sobi Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 104. Sobi Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sobi Recent Developments/Updates
Table 106. Sobi Competitive Strengths & Weaknesses
Table 107. 3SBIO Basic Information, Area Served and Competitors
Table 108. 3SBIO Major Business
Table 109. 3SBIO Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 110. 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. 3SBIO Recent Developments/Updates
Table 112. Innovent Biologics Basic Information, Area Served and Competitors
Table 113. Innovent Biologics Major Business
Table 114. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Product and Services
Table 115. Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Monoclonal Antibody Biologics and Biosimilars Upstream (Raw Materials)
Table 117. Monoclonal Antibody Biologics and Biosimilars Typical Customers
LIST OF FIGURES
Figure 1. Monoclonal Antibody Biologics and Biosimilars Picture
Figure 2. World Monoclonal Antibody Biologics and Biosimilars Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Monoclonal Antibody Biologics and Biosimilars Total Market Size (2018-2029) & (USD Million)
Figure 4. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 13. Monoclonal Antibody Biologics and Biosimilars Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 16. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 18. China Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 23. India Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Monoclonal Antibody Biologics and Biosimilars by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Monoclonal Antibody Biologics and Biosimilars Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Monoclonal Antibody Biologics and Biosimilars Markets in 2022
Figure 27. United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type in 2022
Figure 31. Biologics
Figure 32. Biosimilars
Figure 33. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
Figure 34. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application in 2022
Figure 36. Cancer
Figure 37. Autoimmune Disease
Figure 38. Other
Figure 39. Monoclonal Antibody Biologics and Biosimilars Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Monoclonal Antibody Biologics and Biosimilars Picture
Figure 2. World Monoclonal Antibody Biologics and Biosimilars Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Monoclonal Antibody Biologics and Biosimilars Total Market Size (2018-2029) & (USD Million)
Figure 4. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Monoclonal Antibody Biologics and Biosimilars Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Monoclonal Antibody Biologics and Biosimilars Revenue (2018-2029) & (USD Million)
Figure 13. Monoclonal Antibody Biologics and Biosimilars Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 16. World Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 18. China Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 23. India Monoclonal Antibody Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Monoclonal Antibody Biologics and Biosimilars by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Monoclonal Antibody Biologics and Biosimilars Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Monoclonal Antibody Biologics and Biosimilars Markets in 2022
Figure 27. United States VS China: Monoclonal Antibody Biologics and Biosimilars Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Monoclonal Antibody Biologics and Biosimilars Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type in 2022
Figure 31. Biologics
Figure 32. Biosimilars
Figure 33. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Type (2018-2029)
Figure 34. World Monoclonal Antibody Biologics and Biosimilars Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Monoclonal Antibody Biologics and Biosimilars Market Size Market Share by Application in 2022
Figure 36. Cancer
Figure 37. Autoimmune Disease
Figure 38. Other
Figure 39. Monoclonal Antibody Biologics and Biosimilars Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
